Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings

Journal of Computer Assisted Tomography

Volumn 33, Issue 2, 2009, Pages 298-304

  Krishnan, Anant ^a   Arslanoglu, Atilla ^b   Yildirm, Nadir ^c   Silbergleit, Richard ^a   Aygun, Nafi ^d  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Van Military Hospital   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bisphosphonate; CT; Jaw; Mandible; MRI; Osteonecrosis

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETISM; MEDICAL IMAGING; NUCLEAR MEDICINE; RESONANCE;

BISPHOSPHONATES; BONE SCINTIGRAPHY; CT; IMAGING FEATURES; JAW; MANDIBLE; MEAN AGES; MEDICAL RECORD; OSTEONECROSIS; TEMPORAL CHANGE;

MAGNETIC RESONANCE IMAGING;

ALENDRONIC ACID; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BONE NECROSIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; JAW OSTEONECROSIS; JAW RADIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; JAW DISEASE; MIDDLE AGED; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; JAW DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEONECROSIS; OSTEOPOROSIS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDIES;

EID: 64749113650     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31817e4986     Document Type: Article

References (22)

1. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761.
2. Mortensen M, Lawson W, Montazem A. Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review. Laryngoscope. 2007;117:30-34.
3. Migliorati CA, Siegel MA, Elting LS. Bisphosphonates-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol. 2003;7:508-514.
4. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-1061.
5. Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol. 2005;23:8219-8224.
6. Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology Clinical Practice Guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20:3719-3736.
7. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117.
8. Magopoulos C, Karakinaris G, Telioudis Z, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol. 2007;28:158-163.
9. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534.
10. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N EngI J Med. 2005;353:99-102; discussion 99-102.
11. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-376.
12. Brooks JK, Gilson AJ, Sindler AJ, et al. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:780-786.
13. Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567-1575.
14. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-2410.
15. Hansen T, Kunkel M, Springer E, et al. Actinomycosis of the jaws - histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch. 2007;451:1009-1017.
16. Bachmann G, Rossler R, Klett R, et al. The role of magnetic resonance imaging and scintigraphy in the diagnosis of pathologic changes of the mandible after radiation therapy. Int J Oral Maxillofac Surg. 1996;25:189-195.
17. Hermans R, Fossion E, Ioannides C, et al. CT findings in osteoradionecrosis of the mandible. Skeletal Radiol. 1996;25:31-36.
18. Phal PM, Myall RW, Assael LA, et al. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol. 2007;28:1139-1145.
19. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-1491.
20. Pruckmayer M, Glaser C, Marosi C, et al. Mandibular pain as the leading clinical symptom for metastatic disease: nine cases and review of the literature. Ann Oncol. 1998;9:559-564.
21. Bar-Ziv J, Slasky BS. CT imaging of mental nerve neuropathy: the numb chin syndrome. AJR Am J Roentgenol. 1997;168:371-376.
22. Taguchi A, Suei Y, Ogawa I, et al. Metastatic retinoblastoma of the maxilla and mandible. Dentomaxillofac Radiol. 2005;34: 126-131.